Scientists probe link between cancer therapy and dangerous blood disease
NCT ID NCT06510868
Summary
This study aims to understand if a targeted radiation therapy for neuroendocrine tumors (PRRT) increases the risk of patients later developing serious blood cancers like MDS or AML. Researchers will follow 45 patients for up to 5 years, taking blood samples to look for genetic changes linked to these blood cancers. The goal is to learn how to better select patients for this therapy and find ways to prevent this potential side effect.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROME are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Princess Margaret Cancer Centre
RECRUITINGToronto, Ontario, M5G 2M9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.